Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/12/2017
SIETES contiene 92152 citas

 
 
 1 a 20 de 77 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Diphosphonates: valvulopathies?. Prescrire 2017;37:511-2. [Ref.ID 102010]
4. Cita con resumen
Anónimo. Benfluorex: un bilan 1976-2015. Prescrire 2016;36:755. [Ref.ID 100895]
5. Cita con resumen
Casassus B. Drug scandals in France: have the lessons been learnt?. Lancet 2016;388:550-2. [Ref.ID 100574]
6. Cita con resumen
Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali SK, Webb JG, Mack MJ, Douglas PS, Thourani VH, Babaliaros VC, Hermann HC, Szeto WY, Pichard AD, Williams MR, Fontana GP, Miller DC, Anderson WN, Smith CR, PARTNER trial investigators, Akin J, Davidson MJ. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015;385:2485-91. [Ref.ID 99303]
7. Cita con resumen
Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A D, Hermann HC, Brown DL, Williams M, Davidson MJ, Svensson LG, PARTNER 1 trial investigators, Akin J. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015;385:2477-84. [Ref.ID 99302]
9.
Rueda-Clausen CF, Padwal RS. Pharmacotherapy for weight loss. BMJ 2014;348:g3526. [Ref.ID 98045]
10. Cita con resumen
Stafford N. Jacques Servier. BMJ 2014;348:g3298. [Ref.ID 98043]
11. Cita con resumen
Woloshin S, Schwartz LM. The new weight-loss drugs, Lorcaserin and Phentermine-topiramate. Slim pickings?. JAMA Intern Med 2014;174:615-9. [Ref.ID 97426]
12. Cita con resumen
Anónimo. lorcasérine (Belviq). Obésité: prise de risque inacceptable. Prescrire 2014;34:99. [Ref.ID 97125]
13.Tiene citas relacionadas
Hylek EM. Dabigatran and mechanical heart valves - Not as easy as we hoped. N Engl J Med 2013;369:1264-6. [Ref.ID 96302]
14.Tiene citas relacionadas Cita con resumen
Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, Blatchford J, Stat C, Devenny K, Friedman J, Guiver K, Harper R, Khder Y, Lobmeyer MT, Maas H, Voigt J-U, Simoons ML, Van de Werf F, for the RE-ALIGN Investigators. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med 2013;369:1206-14. [Ref.ID 96301]
15. Cita con resumen
Anónimo. Valvulopathies d'origine médicamenteuse. Prescrire 2013;33:668-72. [Ref.ID 96188]
16. Cita con resumen
Mullard A. Mediator scandal engulfs French compensation body. Lancet 2013;381:1803. [Ref.ID 95500]
17. Cita con resumen
Colman E, Golden J, Roberts M, Egan A, Weaver J, Rosenbraugh C. The FDA's assessment of two drugs for chronic weight management. N Engl J Med 2012;367:1577-9. [Ref.ID 93939]
18. Cita con resumen
Anónimo. Dabigatrán etexilato (Pradaxa®): contraindicación en pacientes con prótesis valvulares cardíacas. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2012:19 de diciembre. [Ref.ID 93887]
19.Tiene citas relacionadas Cita con resumen
Donzé J, Rodondi N, Waeber G, Monney P, Cornuz J, Aujesky D. Scores to predict major bleeding risk during oral anticoagulation therapy: a prospective validation study. Am J Med 2012;125:1095-102. [Ref.ID 93713]
20. Cita con resumen
Montastruc F, Montastruc G, Vigreux P, Bruneval P, Guilbeau-Frugier C, Cron C, Bagheri H, Delisle B, Lapeyre-Mestre M, Pathak A, Montastruc J-L. Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'). Br J Clin Pharmacol 2012;74:547-8. [Ref.ID 93709]
Seleccionar todas
 
 1 a 20 de 77 siguiente >>